Close
Smartlab Europe
Inizio Ignite

Press Releases

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

Pharmapack Europe 2023 (February 1-2, 2023) closed earlier this month with the drug delivery and packaging community predicting sizeable growth through 2023 and sustainability dominating the at show agenda and innovations. The event, widely seen as a key bellwether for pharma packaging...

interpack 2023: Syntegon showcases optimized solutions for the coating and sealing of solid dosage forms

Sepion 175 coater: Human Machine Interface for intuitive operator guidance during setup, process and process monitoring Sepion 175 coater: Flexible coating solution for film and sugar coating of small batch sizes Banding machine GKB 2100: Gentle handling and...

mdgroup launches third fully compliant medical distribution centre in Europe

Amsterdam logistics centre Horreum strengthens links in the clinical trial supply chain, streamlines hybrid and DCT conduct, and creates remarkable patient experiences Bracknell, UK - 28 February 2023 – mdgroup, a leading global MedTech and patient health services company...

New generation of prebiotics and dietary supplements to be under spotlight at Nutraceuticals 2023

More than a hundred companies at the leading edge of the nutraceuticals industry will be in Barcelona on 8th and 9th March showing the latest developments in prebiotic technology and dietary supplements made from natural ingredients, amongst other innovations. Valencia,...

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede for Alpha-Mannosidosis

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has approved Lamzede® (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM)...

Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, announced a strategic research and development collaboration to discover and develop...

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of  messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement to establish a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »